Premature and extensive atheroscleroses involving renal, peripheral, and cardiovascular sites remain major complications of diabetes mellitus. Controversy exists as to the contribution of hyperglycemia versus elevated local or systemic concentrations of insulin to atherosclerosis risk. In this report, we developed the first murine model susceptible to both atherosclerosis and diabetes to determine which diabetogenic factors contribute to vascular disease. C57BL/6 and BALB/c mice were treated with multiple low-dose streptozotocin (STZ) or control citrate buffer and fed rodent chow or an atherogenic-promoting (Ath) diet for 12-20 wk. STZ treatment resulted in sustained hyperglycemia (250-420 mg/dl) and a modest reduction in plasma insulin levels for both strains regardless of diet. Citrate-treated C57BL/6 mice fed the Ath diet showed extensive oil red O-staining fatty streak aortic sinus lesions (20,537+/-2,957 micron2), the size of which did not differ for Ath-fed mice treated with STZ (16,836+/-2,136 micron2). In contrast, hyperglycemic BALB/c mice fed the Ath diet showed a 17-fold increase in atherosclerotic lesion area (7,922+/-2,096 micron2) as compared with citrate-treated mice fed the Ath diet (467+/-318 micron2). Correlations between lesion size and plasma glucose levels were significant for BALB/c (r = 0.741, P < 0.009), but not C57BL/6 (r = 0.314, P<0.3) mice. Lesion size correlated significantly with plasma cholesterol for C57BL/6 (r = 0.612, P<0.03) but not BALB/c (r = 0.630, P<0.1) mice. Immunohistochemistry showed that aortic sinus lesions from both strains contained macrophages, but smooth muscle cells were clearly present in lesions of BALB/c mice. In summary, we present the first small animal model showing accelerated atherosclerosis in response to hyperglycemia. Fatty streaks resembled those of human type II lesions in that both macrophages and smooth muscle cells were evident. In addition, our results support the concept that hyperglycemia as opposed to hyperinsulinemia contributes heavily to risk of atherosclerosis.
V V Kunjathoor, D L Wilson, R C LeBoeuf
Title and authors | Publication | Year |
---|---|---|
Intravenous D‑allose administration improves blood glucose control by maintaining insulin secretion in diabetic mice with transplanted islets
Noge S, Kumamoto K, Matsukawa H, Ando Y, Suto H, Kondo A, Kishino T, Oshima M, Suzuki Y, Okano K |
Experimental and Therapeutic Medicine | 2025 |
The activity of glyoxylase 1 is regulated by glucose-responsive phosphorylation on Tyr136
F Cortizo, D Pfaff, A Wirth, A Schlotterer, R Medert, J Morgenstern, T Weber, H Hammes, T Fleming, P Nawroth, M Freichel, A Teleman |
Molecular Metabolism | 2022 |
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Elrakaybi A, Laubner K, Zhou Q, Hug MJ, Seufert J |
Molecular Metabolism | 2022 |
miR-351 promotes atherosclerosis in diabetes by inhibiting the ITGB3/PIK3R1/Akt pathway and induces endothelial cell injury and lipid accumulation.
Li H, Song D, Liu Q, Li L, Sun X, Guo J, Li D, Li P |
Molecular Medicine | 2022 |
Heart failure in diabetes
S Jankauskas, U Kansakar, F Varzideh, S Wilson, P Mone, A Lombardi, J Gambardella, G Santulli |
Metabolism | 2021 |
Streptozotocin‐Induced Diabetic Models in Mice and Rats
BL Furman |
2021 | |
Heart failure in diabetes
SS Jankauskas, U Kansakar, F Varzideh, S Wilson, P Mone, A Lombardi, J Gambardella, G Santulli |
Metabolism | 2021 |
Diabetic atherosclerosis: is there a role for the hypoxia-inducible factors?
D Pirri, M Fragiadaki, PC Evans |
Bioscience Reports | 2020 |
Regulatory Effects of O-GlcNAcylation in Vascular Smooth Muscle Cells on Diabetic Vasculopathy
CH Byon, SW Kim |
Journal of Lipid and Atherosclerosis | 2020 |
Peroral administration of beauverolides allows their transport into the peripheral blood and urine
P Heneberg, A Jegorov, P Šimek |
CYTA-J FOOD | 2020 |
Ameliorative and Preventive Effects of Metformin, Nigella sativa, Punica granatum and Zingeber officinale on Bone Damage and Infections Caused by Diabetes mellitus in Animal Model
NA Jalaud |
J PURE APPL MICROBIO | 2019 |
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr −/− type 1 diabetic mice
A Al-Sharea, AJ Murphy, LA Huggins, Y Hu, IJ Goldberg, PR Nagareddy |
Atherosclerosis | 2018 |
Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis
, LH Zhong, A Huang, A Deng, GH Werstuck |
Metabolomics | 2018 |
The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production
H Alkhalidy, W Moore, Y Wang, J Luo, R McMillan, W Zhen, K Zhou, D Liu |
Molecules (Basel, Switzerland) | 2018 |
Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity
B Giri, S Dey, T Das, M Sarkar, J Banerjee, SK Dash |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2018 |
Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes
M Tsujita, MA Hossain, R Lu, T Tsuboi, K Okumura-Noji, S Yokoyama |
Journal of Atherosclerosis and Thrombosis | 2017 |
A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans
S Nath, SK Ghosh, Y Choudhury |
Journal of Pharmacological and Toxicological Methods | 2017 |
Dietary glutamine supplementation enhances endothelial progenitor cell mobilization in streptozotocin-induced diabetic mice subjected to limb ischemia
ST Su, CL Yeh, YC Hou, MH Pai, SL Yeh |
The Journal of Nutritional Biochemistry | 2017 |
A Hepatic GAbp-AMPK Axis Links Inflammatory Signaling to Systemic Vascular Damage
K Niopek, BE Üstünel, S Seitz, M Sakurai, A Zota, F Mattijssen, X Wang, T Sijmonsma, Y Feuchter, AM Gail, B Leuchs, D Niopek, O Staufer, M Brune, C Sticht, N Gretz, K Müller-Decker, HP Hammes, P Nawroth, T Fleming, MD Conkright, M Blüher, A Zeigerer, S Herzig, MB Diaz |
Cell Reports | 2017 |
Increasing Atherosclerosis in Streptozotocin-Induced Diabetes into Four Groups of Mice
K Ritarwan, A Lelo, YS Pane, N Nerdy |
Open Access Macedonian Journal of Medical Sciences | 2017 |
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations
CC Wang, CN Hess, WR Hiatt, AB Goldfine |
Circulation | 2016 |
Large animal models of cardiovascular disease: Cardiovascular Disease Models
HG Tsang, NA Rashdan, CB Whitelaw, BM Corcoran, KM Summers, VE MacRae |
Cell Biochemistry and Function | 2016 |
Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
M von Scheidt, Y Zhao, Z Kurt, C Pan, L Zeng, X Yang, H Schunkert, AJ Lusis |
Cell Metabolism | 2016 |
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
S Gargiulo, M Gramanzini, M Mancini |
International journal of molecular sciences | 2016 |
Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice
J Peng, K Hui, C Hao, Z Peng, QX Gao, Q Jin, G Lei, J Min, Z Qi, C Bo, QN Dong, ZH Bing, XY Jia, DL Fu |
Connective Tissue Research | 2016 |
A novel organ culture model of aorta for vascular calcification
T Akiyoshi, H Ota, K Iijima, BK Son, T Kahyo, M Setou, S Ogawa, Y Ouchi, M Akishita |
Atherosclerosis | 2016 |
Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches
SE Heinonen, G Genové, E Bengtsson, T Hübschle, L Åkesson, K Hiss, A Benardeau, S Ylä-Herttuala, AC Jönsson-Rylander, MF Gomez |
Journal of Diabetes Research | 2015 |
Unbreak My Heart: Targeting Mitochondrial Autophagy in Diabetic Cardiomyopathy
DA Kubli, ÅB Gustafsson |
Antioxidants & Redox Signaling | 2015 |
Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs
RH Al-Mashhadi, MM Bjørklund, MB Mortensen, C Christoffersen, T Larsen, E Falk, JF Bentzon |
Diabetologia | 2015 |
Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture: Figure 1
KE Bornfeldt |
Diabetes | 2015 |
Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
GP Chen, XQ Zhang, T Wu, L Li, J Han, CQ Du |
Journal of Diabetes Research | 2015 |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition
RN Bergman, M Ader |
International Textbook of Diabetes Mellitus: DeFronzo/International Textbook of Diabetes Mellitus, Fourth Edition | 2015 |
Current Protocols in Pharmacology: Streptozotocin-Induced Diabetic Models
BL Furman |
Current Protocols in Pharmacology: Streptozotocin-Induced Diabetic Models | 2015 |
Atherosclerosis: Risks, Mechanisms, and Therapies
HJ Pownall, C Rosales, BK Gillard, AM Gotto |
Atherosclerosis: Risks, Mechanisms, and Therapies | 2015 |
Effect of aqueous extract of Annona muricata seed on atherogenicity in streptozotocin-induced diabetic rats
EO Agbai, CJ Njoku, CO Nwanegwo, A Nwafor |
AFR J PHARM PHARMACO | 2015 |
2013 Russell Ross Memorial Lecture in Vascular Biology: Cellular and Molecular Mechanisms of Diabetes Mellitus-Accelerated Atherosclerosis
KE Bornfeldt |
Arteriosclerosis, thrombosis, and vascular biology | 2014 |
Genetic determinants of atherosclerosis, obesity, and energy balance in consomic mice
SH Spiezio, LM Amon, TS McMillen, CM Vick, BA Houston, M Caldwell, K Ogimoto, GJ Morton, EA Kirk, MW Schwartz, JH Nadeau, RC LeBoeuf |
Mammalian Genome | 2014 |
Differential MMP-9 activity in CD34+progenitor cell-derived foam cells from diabetic and normoglycemic patients
JU Schmohl, K Daub, SN von Ungern-Sternberg, S Lindemann, T Schönberger, T Geisler, M Gawaz, P Seizer |
Herz | 2013 |
Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
DE Venegas-Pino, N Banko, MI Khan, Y Shi, GH Werstuck |
Journal of visualized experiments : JoVE | 2013 |
Atherosclerosis and cardiac function assessment in low-density lipoprotein receptor-deficient mice undergoing body weight cycling
TS McMillen, E Minami, RC Leboeuf |
Nutrition and Diabetes | 2013 |
Connective Tissue Growth Factor (CTGF) Expression Modulates Response to High Glucose
LR James, C Le, H Doherty, HS Kim, N Maeda, JC Dussaule |
PloS one | 2013 |
PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress
Y Wu, H Zhou, K Wu, S Lee, R Li, X Liu |
Antioxidants & Redox Signaling | 2013 |
Mechanisms of Diabetic Complications
JM Forbes, ME Cooper |
Physiological reviews | 2013 |
Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways
JS Chen, YH Chen, PH Huang, HY Tsai, YL Chen, SJ Lin, JW Chen |
Cardiovascular Diabetology | 2012 |
AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics
P Mocharla, S Briand, G Giannotti, C Dorries, P Jakob, F Paneni, T Luscher, U Landmesser |
Blood | 2012 |
Insulin Resistance, Hyperglycemia, and Atherosclerosis
KE Bornfeldt, I Tabas |
Cell Metabolism | 2011 |
Increase in GLUT1 in Smooth Muscle Alters Vascular Contractility and Increases Inflammation in Response to Vascular Injury
N Adhikari, DL Basi, M Carlson, A Mariash, Z Hong, U Lehman, S Mullegama, EK Weir, JL Hall |
Arteriosclerosis, thrombosis, and vascular biology | 2011 |
Painless Skin Electroporation as a Novel Way for Insulin Delivery
TW Wong, TY Chen, CC Huang, JC Tsai, SW Hui |
Diabetes Technology & Therapeutics | 2011 |
Salutary Effect of Cassia auriculata L. Leaves on Hyperglycemia-Induced Atherosclerotic Environment in Streptozotocin Rats
S Gupta, SB Sharma, UR Singh, SK Bansal |
Cardiovascular Toxicology | 2011 |
Glucosamine-supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherogenesis in apoE−/− mice
DR Beriault, S Sharma, Y Shi, MI Khan, GH Werstuck |
Atherosclerosis | 2011 |
In vivo bioluminescence imaging of inducible nitric oxide synthase gene expression in vascular inflammation
M Terashima, S Ehara, E Yang, H Kosuge, PS Tsao, T Quertermous, CH Contag, MV McConnell |
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging | 2011 |
Role of diabetes, hypertension, and cigarette smoking on atherosclerosis
RK Mathur |
Journal of cardiovascular disease research | 2010 |
Short-term hyperglycaemia causes non-reversible changes in arterial gene expression in a fully ‘switchable’ in vivo mouse model of diabetes
S Zervou, YF Wang, A Laiho, A Gyenesei, L Kytömäki, R Hermann, S Abouna, D Epstein, S Pelengaris, M Khan |
Diabetologia | 2010 |
Macrovascular complications of diabetes in atherosclerosisprone mice
LA Johnson, N Maeda |
Expert Review of Endocrinology & Metabolism | 2010 |
Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice
JJ Manning-Tobin, KJ Moore, TA Seimon, SA Bell, M Sharuk, JI Alvarez-Leite, MP de Winther, I Tabas, MW Freeman |
Arteriosclerosis, thrombosis, and vascular biology | 2009 |
Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus
ED Falco, D Avitabile, P Totta, S Straino, F Spallotta, C Cencioni, AR Torella, R Rizzi, D Porcelli, A Zacheo, LD Vito, G Pompilio, M Napolitano, G Melillo, MC Capogrossi, M Pesce |
Journal of Cellular and Molecular Medicine | 2009 |
Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis
AJ Bowes, MI Khan, Y Shi, L Robertson, GH Werstuck |
The American Journal of Pathology | 2009 |
Evidence Supporting a Role for Endoplasmic Reticulum Stress in the Development of Atherosclerosis in a Hyperglycaemic Mouse Model
MI Khan, BA Pichna, Y Shi, AJ Bowes, GH Werstuck |
Antioxidants & Redox Signaling | 2009 |
Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes
IJ Goldberg, Y Hu, HL Noh, J Wei, LA Huggins, MG Rackmill, H Hamai, BN Reid, WS Blaner, LS Huang |
Diabetes | 2008 |
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies
G Spinetti, N Kraenkel, C Emanueli, P Madeddu |
Cardiovascular Research | 2008 |
Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes
DK Arulmozhi, R Kurian, SL Bodhankar, A Veeranjaneyulu |
Journal of Pharmacy and Pharmacology | 2008 |
Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents
J Zhou, RJ Martin, RT Tulley, AM Raggio, KL McCutcheon, L Shen, SC Danna, S Tripathy, M Hegsted, MJ Keenan |
American journal of physiology. Endocrinology and metabolism | 2008 |
Mouse Models for Studies of Cardiovascular Complications of Type 1 Diabetes
X Shen, KE Bornfeldt |
Annals of the New York Academy of Sciences | 2007 |
The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats
M Kanter, MF Altan, S Donmez, A Ocakci, ME Kartal |
Cell Biochemistry and Function | 2007 |
Diabetic atherosclerosis mouse models
KK Wu, Y Huan |
Atherosclerosis | 2007 |
Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats
MF Altan, M Kanter, S Donmez, ME Kartal, S Buyukbas |
Acta Histochemica | 2007 |
Regulation of Vascular Proteoglycan Synthesis by Metabolic Factors Associated with Diabetes:
P Wilson, K Drennon, LR Tannock |
Journal of Investigative Medicine | 2007 |
Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability
J Benton, A Powers, L Eiselein, R Fitch, D Wilson, AC Villablanca, JC Rutledge |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2007 |
Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes
T Shoji, H Koyama, T Morioka, S Tanaka, A Kizu, K Motoyama, K Mori, S Fukumoto, A Shioi, N Shimogaito, M Takeuchi, Y Yamamoto, H Yonekura, H Yamamoto, Y Nishizawa |
Diabetes | 2006 |
Current Protocols in Pharmacology
JP Renninger |
Current Protocols in Pharmacology | 2006 |
Plasminogen Activator Inhibitor-1 Deficiency Has Renal Benefits but Some Adverse Systemic Consequences in Diabetic Mice
SJ Collins, SL Alexander, JM Lopez-Guisa, X Cai, R Maruvada, SC Chua, G Zhang, DM Okamura, S Matsuo, AA Eddy |
Nephron Experimental Nephrology | 2006 |
Cellular mechanisms and signalling pathways activated by high glucose and AGE-albumin in the aortic endothelium
D Popov, M Simionescu |
Archives Of Physiology And Biochemistry | 2006 |
Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?
C Renard, EV Obberghen |
Diabetes & Metabolism | 2006 |
Loss of scavenger receptor mediated lipid uptake via SR-A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
Kathryn J. Moore, Vidya V. Kunjathoor, Stephanie L. Koehn, Jennifer J. Manning, Anita A. Tseng, Jessica M. Silver, Mary McKee and Mason W. Freeman |
Journal of Clinical Investigation | 2005 |
Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice
JA Berti, AG Salerno, EJ Bighetti, AC Casquero, AC Boschero, HC Oliveira |
APMIS | 2005 |
Development of atherosclerosis in the diabetic BALB/c mice
P Otero, B Bonet, E Herrera, A Rabano |
Atherosclerosis | 2005 |
Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor
KK Wu, TJ Wu, J Chin, LJ Mitnaul, M Hernandez, TQ Cai, N Ren, MG Waters, SD Wright, K Cheng |
Atherosclerosis | 2005 |
Glucosamine-Induced Endoplasmic Reticulum Dysfunction Is Associated With Accelerated Atherosclerosis in a Hyperglycemic Mouse Model
GH Werstuck, MI Khan, G Femia, AJ Kim, V Tedesco, B Trigatti, Y Shi |
Diabetes | 2005 |
Role of lipids in the early developmental stages of experimental immune diabetes induced by multiple low-dose streptozotocin
D Pighin, L Karabatas, C Pastorale, E Dascal, C Carbone, A Chicco, YB Lombardo, JC Basabe |
Journal of applied physiology | 2005 |
Diabetes and Diabetes-Associated Lipid Abnormalities Have Distinct Effects on Initiation and Progression of Atherosclerotic Lesions
Catherine B. Renard, Farah Kramer, Fredrik Johansson, Najib Lamharzi, Lisa R. Tannock, Matthias G. von Herrath, Alan Chait, Karin E. Bornfeldt |
Journal of Clinical Investigation | 2004 |
Epidermal cells accelerate the restoration of the blood flow in diabetic ischemic limbs
C Jiao, S Bronner, KL Mercer, DD Sheriff, GC Schatteman, M Dunnwald |
Journal of cell science | 2004 |
Cellular and Molecular Mechanisms of Atherosclerosis with Mouse Models
R Ohashi, H Mu, Q Yao, C Chen |
Trends in Cardiovascular Medicine | 2004 |
Why does diabetes increase atherosclerosis? I don’t know!
IJ Goldberg |
Journal of Clinical Investigation | 2004 |
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
KS Michelsen, TM Doherty, PK Shah, M Arditi |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice
IJ Goldberg, A Isaacs, E Sehayek, JL Breslow, LS Huang |
Atherosclerosis | 2004 |
Repeated Streptozotocin Injections Cause Early Onset of Glomerulosclerosis in Mice
S MIZUNO, J WEN, Y MIZUNO-HORIKAWA |
Experimental Animals | 2004 |
How the Davis 2.36 ATA wound healing enhancement treatment table was established
L Park, KG Raman, KJ Lee, Y Lu, LJ Ferran, WS Chow, D Stern, AM Schmidt |
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc | 2004 |
How the Davis 2.36 ATA wound healing enhancement treatment table was established
L Park, KG Raman, KJ Lee, Y Lu, LJ Ferran, WS Chow, D Stern, AM Schmidt |
Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc | 2004 |
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
KS Michelsen, TM Doherty, PK Shah, M Arditi |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
Hepatic Gene Expression Profiling of Streptozotocin-Induced Diabetes
JM Dhahbi, PL Mote, SX Cao, SR Spindler |
Diabetes Technology & Therapeutics | 2003 |
Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity
SA Schreyer, TC Lystig, CM Vick, RC LeBoeuf |
Atherosclerosis | 2003 |
Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy
SM Hammad, L Powell-Braxton, JD Otvos, L Eldridge, W Won, TJ Lyons |
Metabolism | 2003 |
Response to sex hormones differs in atherosclerosis-susceptible and -resistant mice
M Potier, M Karl, SJ Elliot, GE Striker, LJ Striker |
American journal of physiology. Endocrinology and metabolism | 2003 |
Diabetes Interferes with the Bone Formation by Affecting the Expression of Transcription Factors that Regulate Osteoblast Differentiation
H Lu, D Kraut, LC Gerstenfeld, DT Graves |
Endocrinology | 2003 |
Atlas of Atherosclerosis
PW Wilson |
2003 | |
Hepatic Expression of Microsomal Triglyceride Transfer Protein and In Vivo Secretion of Triglyceride-Rich Lipoproteins Are Increased in Obese Diabetic Mice
ED Bartels, M Lauritsen, LB Nielsen |
Diabetes | 2002 |
Overexpression of Apolipoprotein B in the Heart Impedes Cardiac Triglyceride Accumulation and Development of Cardiac Dysfunction in Diabetic Mice
LB Nielsen, ED Bartels, E Bollano |
The Journal of biological chemistry | 2002 |
Accumulation of Biglycan and Perlecan, but Not Versican, in Lesions of Murine Models of Atherosclerosis
VV Kunjathoor, DS Chiu, KD OBrien, RC LeBoeuf |
Arteriosclerosis, thrombosis, and vascular biology | 2002 |
Lipoprotein lipase deficiency and CETP in streptozotocin-treated apoB-expressing mice
Y Kako, M Massé, LS Huang, AR Tall, IJ Goldberg |
Journal of lipid research | 2002 |
Iron overload diminishes atherosclerosis in apolipoprotein e-deficient mice
Elizabeth A. Kirk, Jay W. Heinecke, and Renee C. LeBoeuf |
Journal of Clinical Investigation | 2001 |
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
L Makowski, JB Boord, K Maeda, VR Babaev, KT Uysal, MA Morgan, RA Parker, J Suttles, S Fazio, GS Hotamisligil, MF Linton |
Nature Medicine | 2001 |
Genetic Modifiers of Atherosclerosis in Mice
JD Smith, HM Dansky, JL Breslow |
Annals of the New York Academy of Sciences | 2001 |
Non-obese diabetic (NOD) mice exhibit an increased cellular immune response to glycated-LDL but are resistant to high fat diet induced atherosclerosis
P Keren, J George, G Keren, D Harats |
Atherosclerosis | 2001 |
CD34−Blood-Derived Human Endothelial Cell Progenitors
M Harraz, C Jiao, HD Hanlon, RS Hartley, GC Schatteman |
Stem Cells | 2001 |
Cardiovascular structure and function in baboons with Type 1 diabetes — a transvenous ultrasound study
U Premawardhana, MR Adams, A Birrell, DK Yue, DS Celermajer |
Journal of Diabetes and its Complications | 2001 |
The lipid-lowering effect of trans-dehydrocrotonin, a clerodane diterpene from Croton cajucara Benth. in mice fed on high-fat diet
R M Silva, F A Santos, V S Rao, M A Maciel, A C Pinto |
The Journal of pharmacy and pharmacology | 2001 |
Delayed catabolism of apoB48 lipoproteins in streptozotocin-treated mice: evidence that diabetes leads to a selective alteration in the heparan sulfate proteoglycan pathway of chylomicron remnant degradation
Tetsu Ebara, Karin Conde, Yuko Kako, Yan Xu, Rajasekhar Ramakrishnan, Ira J. Goldberg, Neil S. Shachter |
Journal of Clinical Investigation | 2000 |
Blood-derived angioblasts accelerate blood flow restoration in diabetic mice
Gina C. Schatteman, Heather D. Hanlon, Chunhua Jiao, Sherry G. Dodds, Barbara A. Christy |
Journal of Clinical Investigation | 2000 |
Aortic Atheromatous Lesions Developed in APA Hamsters with Streptozotocin induced Diabetes: A New Animal Model for Diabetic Atherosclerosis. 1. Histopathological Studies
J YAMANOUCHI, E NISHIDA, S ITAGAKI, S KAWAMURA, K DOI, Y YOSHIKAWA |
Experimental Animals | 2000 |
Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries
C Agardh |
Journal of Diabetes and its Complications | 2000 |
Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice
EA Kirk, MC Dinauer, H Rosen, A Chait, JW Heinecke, RC LeBoeuf |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene
K Reue, P Xu, XP Wang, BG Slavin |
Journal of lipid research | 2000 |
Hyperglycemia Inhibits Vascular Smooth Muscle Cell Apoptosis Through a Protein Kinase C–Dependent Pathway
JL Hall, CM Matter, X Wang, GH Gibbons |
Circulation research | 2000 |
Genetic modifiers of atherosclerosis in mice.
Knowles JW, Maeda N |
Arteriosclerosis, thrombosis, and vascular biology | 2000 |
Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17β-estradiol
J Tse, B Martin-McNaulty, M Halks-Miller, K Kauser, V DelVecchio, R Vergona, ME Sullivan, GM Rubanyi |
Atherosclerosis | 1999 |
Emerging therapeutic targets in diabetic vascular disease
AM Schmidt, DM Stern |
Expert Opinion on Therapeutic Targets | 1999 |
Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia
A Ceriello, N Bortolotti, E Motz, C Pieri, M Marra, L Tonutti, S Lizzio, F Feletto, B Catone, C Taboga |
Metabolism | 1999 |
Interleukin-1beta-induced nitric oxide production in rat aortic endothelial cells: Inhibition by estradiol in normal and high glucose cultures
R Xu, JA Morales, R Muniyappa, DF Skafar, JL Ram, JR Sowers |
Life Sciences | 1999 |
Activation of Receptor for Advanced Glycation End Products: A Mechanism for Chronic Vascular Dysfunction in Diabetic Vasculopathy and Atherosclerosis
AM Schmidt, SD Yan, JL Wautier, D Stern |
Circulation research | 1999 |
Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis
Y Kako, LS Huang, J Yang, T Katopodis, R Ramakrishnan, IJ Goldberg |
Journal of lipid research | 1999 |
Quantitative trait loci analysis for the differences in susceptibility to atherosclerosis and diabetes between inbred mouse strains C57BL/6J and C57BLKS/J
JL Mu, JK Naggert, KL Svenson, GB Collin, JH Kim, C McFarland, PM Nishina, DM Levine, KJ Williams, B Paigen |
Journal of lipid research | 1999 |
C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis
SA Schreyer, DL Wilson, RC LeBoeuf |
Atherosclerosis | 1998 |
Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients
K Ichikawa, M Yoshinari, M Iwase, M Wakisaka, Y Doi, K Iino, M Yamamoto, M Fujishima |
Atherosclerosis | 1998 |
Cardiovascular risk continuum: implications of insulin resistance and diabetes
WA Hsueh, RE Law |
The American Journal of Medicine | 1998 |
Dietary Isoflavones Reduce Plasma Cholesterol and Atherosclerosis in C57BL/6 Mice but not LDL Receptor–Deficient Mice
EA Kirk, P Sutherland, SA Wang, A Chait, RC LeBoeuf |
The Journal of nutrition | 1998 |
Dietary Antioxidants Inhibit Development of Fatty Streak Lesions in the LDL Receptor–Deficient Mouse
RS Crawford, EA Kirk, ME Rosenfeld, RC LeBoeuf, A Chait |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Interaction of Diabetes and Hypertension on Determinants of Endothelial Adhesiveness
PS Tsao, J Niebauer, R Buitrago, PS Lin, B Wang, JP Cooke, YI Chen, GM Reaven |
Arteriosclerosis, thrombosis, and vascular biology | 1998 |
Absence of P-selectin delays fatty streak formation in mice
RC Johnson, SM Chapman, ZM Dong, JM Ordovas, TN Mayadas, J Herz, RO Hynes, EJ Schaefer, DD Wagner |
Journal of Clinical Investigation | 1997 |
Determinants of coronary vascular disease in patients with type ii diabetes mellitus and their therapeutic implications
DJ Schneider, BE Sobel |
Clinical Cardiology | 1997 |
Reduced Myocardial Flow Reserve in Non–Insulin-Dependent Diabetes Mellitus
IY MD, SM MD, TO MD, KY MD, JN MD, YS MD, MO MD |
Journal of the American College of Cardiology | 1997 |
Accelerated Atherosclerosis in Mice Lacking Tumor Necrosis Factor Receptor p55
SA Schreyer, JJ Peschon, RC LeBoeuf |
The Journal of biological chemistry | 1996 |